- Home
- Publications
- Publication Search
- Publication Details
Title
Cytokine-induced killer cells promote antitumor immunity
Authors
Keywords
Tumor Infiltrate Lymphocyte, Cytolytic Activity, Adoptive Cell Therapy, Metastatic Clear Cell Renal Cell Carcinoma, Antitumor Cytolytic Activity
Journal
Journal of Translational Medicine
Volume 11, Issue 1, Pages 83
Publisher
Springer Nature
Online
2013-03-28
DOI
10.1186/1479-5876-11-83
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized Study of Autologous Cytokine-Induced Killer Cell Immunotherapy in Metastatic Renal Carcinoma
- (2012) L. Liu et al. CLINICAL CANCER RESEARCH
- CSPG4 as a Target of Antibody-Based Immunotherapy for Malignant Mesothelioma
- (2012) Z. Rivera et al. CLINICAL CANCER RESEARCH
- Ex Vivo Allogeneic Stimulation Significantly Improves Expansion of Cytokine-Induced Killer Cells Without Increasing Their Alloreactivity Across HLA Barriers
- (2012) Maja Todorovic et al. JOURNAL OF IMMUNOTHERAPY
- New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer
- (2012) David F Stroncek et al. Journal of Translational Medicine
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- PD-1 and BTLA and CD8+T-cell “exhaustion” in cancer
- (2012) Cara Haymaker et al. OncoImmunology
- High Mobility Group Box 1 (HMGB1) Activates an Autophagic Response to Oxidative Stress
- (2011) Daolin Tang et al. ANTIOXIDANTS & REDOX SIGNALING
- Adoptive Immunotherapy with Cytokine-Induced Killer Cells for Patients with Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation
- (2011) Ginna G. Laport et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity
- (2011) A. Pievani et al. BLOOD
- Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
- (2011) R. J. Brentjens et al. BLOOD
- Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates
- (2011) W. H. Fridman et al. CANCER RESEARCH
- Adoptive Transfer of Autologous Natural Killer Cells Leads to High Levels of Circulating Natural Killer Cells but Does Not Mediate Tumor Regression
- (2011) M. R. Parkhurst et al. CLINICAL CANCER RESEARCH
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
- (2011) S. A. Rosenberg et al. CLINICAL CANCER RESEARCH
- Principles and Current Strategies for Targeting Autophagy for Cancer Treatment
- (2011) R. K. Amaravadi et al. CLINICAL CANCER RESEARCH
- IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+T cells
- (2011) Qianting Yang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Bispecific antibodies engage T cells for antitumor immunotherapy
- (2011) Bryan D Choi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
- (2011) Paul F. Robbins et al. JOURNAL OF CLINICAL ONCOLOGY
- Defining the critical hurdles in cancer immunotherapy
- (2011) Bernard A Fox et al. Journal of Translational Medicine
- Combining cytokine-induced killer cells with vaccination in cancer immunotherapy: More than one plus one?
- (2011) Sharmilan Thanendrarajan et al. LEUKEMIA RESEARCH
- Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
- (2011) M. Michaud et al. SCIENCE
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19
- (2010) J. N. Kochenderfer et al. BLOOD
- IL-12 enhances efficacy and shortens enrichment time in cytokine-induced killer cell immunotherapy
- (2010) Mike W. Helms et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Enhancement of effector CD8+T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites
- (2010) Hiroko Kobori et al. IMMUNOLOGY
- Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC)
- (2010) C. Hontscha et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Endogenous HMGB1 regulates autophagy
- (2010) Daolin Tang et al. JOURNAL OF CELL BIOLOGY
- Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients
- (2010) Jing-Ting Jiang WORLD JOURNAL OF GASTROENTEROLOGY
- Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
- (2009) L. A. Johnson et al. BLOOD
- Immunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trial
- (2009) Paola Olioso et al. HEMATOLOGICAL ONCOLOGY
- Experimental study on the treatment of intracerebral glioma xenograft with human cytokine-induced killer cells
- (2008) Peng Wang et al. CELLULAR IMMUNOLOGY
- A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma
- (2008) Dong Hui et al. DIGESTIVE AND LIVER DISEASE
- Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriers
- (2008) Dario Sangiolo et al. INTERNATIONAL IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now